相关实验视频
Updated: Jun 12, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
一种可诱导DNA损伤的癌症/丸长非编码RNAPITAR通过结合和稳定TRIM28mRNA来使p53失活
Samarjit Jana1, Mainak Mondal1, Sagar Mahale2
1Department of Microbiology and Cell Biology, Indian Institute of Science Bangalore, Bangalore, India.
eLife
|September 20, 2024
概括
一种新型的长非编码RNA,PITAR (p53 失活TRIM28关联RNA),通过稳定TRIM28.通过使质母细胞瘤中的p53失活. 抑制PITAR可以减少瘤的生长,并增强化疗抵抗力,这表明它是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 野生型p53 (WT p53) 瘤可以表现出替代的p53失活机制.
- 质母细胞瘤 (GBM) 和质母细胞类干细胞 (GSCs) 经常表现出改变的p53调节.
研究的目的:
- 确定癌症中p53无活化的新型调节剂.
- 研究长非编码RNA PITAR在质母细胞瘤中的作用.
主要方法:
- RNA免疫沉 (RIP) 测试用于识别PITAR目标.
- 西方涂抹测试用于评估TRIM28和p53.3的蛋白质水平.
- 在体外和体内测试以评估PITAR对GSC生长和瘤进展的影响.
主要成果:
- 皮达直接针对TRIM28mRNA,使其稳定并增加TRIM28蛋白水平.
- 升高的TRIM28会导致增强的p53无化和降低的p53水平.
- PITAR是由p53独立的DNA损伤激活的,形成一个反循环.
- PITAR静音抑制了GSC生长和质瘤瘤的进展,而过度表达促进了生长和Temozolomide耐药性.
结论:
- 在GBM中,PITAR代表了p53无活化的替代机制.
- PITAR通过减弱DNA损伤反应,作为一种致癌性 lncRNA 的功能.
- 皮特 (PITAR) 是一种潜在的治疗质母细胞瘤治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K

